Search - tctmd.com

Displaying 161 - 180 of 1011

Sort: Relevancy | Date

Good Results For TAVI in Bicuspid Valves, But Questions Persist

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

COVID-19: TCTMD’s Dispatch for March Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 2

March 07, 2022

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 2

February 07, 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

February 02, 2022

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

News Daily News

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Yael L. Maxwell

January 24, 2022

Conversations in Cardiology: Time for an Interventional Fellowship Match?

News Opinion Conversations in Cardiology

Conversations in Cardiology: Time for an Interventional Fellowship Match?

January 24, 2022

‘Home Time’ Validated as TAVI Outcomes Performance Metric

News Daily News

‘Home Time’ Validated as TAVI Outcomes Performance Metric

January 11, 2022

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

News Daily News

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

December 28, 2021

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

November 30, 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time

News Conference News AHA 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

November 14, 2021

RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor

News Conference News AHA 2021

RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor

Yael L. Maxwell

November 13, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

November 05, 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

November 01, 2021

Good TAVI Outcomes in Young Patients, but Population Is Unique

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

October 20, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.